Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 212 results found. Search for [ covid vaccine makers in india ]

Results 1 to 21 of 212
BusinessToday.In
June 15, 2021
An animal study conducted by Bharat Biotech in 2020 also indicated it uses newborn calf serum in making vaccines. Research paper, released by ICMR and Bharat Biotech, said blood serum from newborn cattle is one of the ingredients used in making Covaxin


BusinessToday.In
June 11, 2021
While the government is in advanced talks with the companies, the high price tag is likely to act as a deterrent for bulk procurement of Moderna and Pfizer vaccines


PTI
June 10, 2021
The Ministry of External Affairs (MEA) also said that it was in touch with the Chinese side in order to seek an early resumption of travel by Indian citizens to China


PTI
June 10, 2021
As against a 23-times growth in personal loans under Rs 25,000 in 2020, as against 2017, the number of consumers checking their credit scores has grown only three times in 2020 when compared to 2018, Transunion Cibil said in a report


Reuters
June 10, 2021
The government relaxed rules last month to potentially allow third-party apps to offer vaccine bookings and has taken back control of procurement from states following delays and shortages


Reuters
June 10, 2021
India has not granted indemnity to any COVID-19 vaccine maker, but the sources said the government was having a change of heart


BusinessToday.In
June 8, 2021
While all citizens, irrespective of their income status, are entitled to free vaccination, those who have the ability to pay are encouraged to use vaccination centres of private hospitals.


BusinessToday.In
June 8, 2021
The guidelines said that states/UTs can decide their own prioritisation in the age group of those above 18 years, factoring in the vaccine supply schedule.


BusinessToday.In
June 7, 2021
Talks between the government and the company are on for import of the Pfizer-BioNTech vaccine. The government is likely to grant indemnity but is not too keen to give in on legal jurisdiction


Raj Chengappa|Rajeev Dubey
June 6, 2021
In an exclusive interview with India Today Group Editorial Director Raj Chengappa and Business Today Editor Rajeev Dubey, Union Finance Minister Nirmala Sitharaman said the scale and intensity of the second wave are sharply different from the first one


Rashi Bisaria
New Delhi, June 3, 2021
COVID-19 impact: Reliance to pay full salary of deceased employee for five yearsIn an attempt to help families of employees that have lost members to COVID-19, Mukesh Ambani-helmed Reliance Industries has announced that it will continue to pay the last-drawn salary of the deceased employee to his or her nominee for the next five years. The company said that it will also support the education of their children till they graduate from college.I-T collection beats corporate tax collection for...


BusinessToday.In
June 3, 2021
This development comes a day after reports suggested that the Centre is leaning towards granting indemnity to foreign vaccine makers including Pfizer and Moderna


PB Jayakumar
June 2, 2021
The acquisition of Akorn India helped Biological E create a potential overall manufacturing capacity of over 1 billion doses per annum.


BusinessToday.In
June 2, 2021
Like other nations, the Indian government is also expected to grant indemnity to foreign drugmakers like Pfizer and Moderna if they seek drug regulator's nod for the Emergency Use Authorisation (EUA)


PB Jayakumar
June 2, 2021
DCGI said the requirement of conducting post approval bridging clinical trials and requirement of testing of every batch of vaccine by the CDL can be exempted, if the vaccine lot/batch is certified and released by National Control Laboratory of country of origin


Nevin John
May 28, 2021
In the first four months (January-April), iron ore exports from India increased by 66 per cent to 22.42 million tonne (MT). About 90 per cent of the export goes to China


Reuters
May 27, 2021
India has been inoculating its people with the AstraZeneca vaccine produced locally at the Serum Institute, Covaxin made by local firm Bharat Biotech, and has begun rolling out Russia's Sputnik V


BusinessToday.In
May 27, 2021
Two vaccines developed by China National Biotech Group Co, which is a unit of Sinopharm, showed the efficacy of 72.8 per cent and 78.1 per cent, respectively. The current efficacy rate largely falls in line with Sinopharm's previous claims


Nidhi Singal
May 27, 2021
Samsung says LDS syringes will minimise the amount of drug left in the syringes after an injection, reducing vaccine wastage, and enable 20 per cent more people to get the dose with the same amount of vaccine


BusinessToday.In
May 26, 2021
Talks with the makers of Sputnik V are on. They will give us a vaccine, but the quantity is yet to be decided. Our officials and the representatives of the vaccine manufacturers met on Tuesday too, Kejriwal said


PAGES 1 OF 11  12345